MOORE JOHN R

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 11. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 11
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Edgewise Therapeutics, Inc.General CounselAwardnothing paid65,000 sharesAug 17, 2026Edgewise Therapeutics, Inc.General Counselnothing paidAward · Aug 17Award65,000Aug 17, 2026
Edgewise Therapeutics, Inc.General CounselAwardnothing paid65,000 sharesAug 14, 2026Edgewise Therapeutics, Inc.General Counselnothing paidAward · Aug 14Award65,000Aug 14, 2026
Edgewise Therapeutics, Inc.General CounselAwardnothing paid32,500 sharesAug 14, 2026Edgewise Therapeutics, Inc.General Counselnothing paidAward · Aug 14Award32,500Aug 14, 2026
Edgewise Therapeutics, Inc.General CounselOption exercisenothing paid6,718 sharesAug 14, 2026Edgewise Therapeutics, Inc.General Counselnothing paidExercise · Aug 14Option exercise6,718Aug 14, 2026
Edgewise Therapeutics, Inc.General CounselOption exercisenothing paid5,781 sharesAug 14, 2026Edgewise Therapeutics, Inc.General Counselnothing paidExercise · Aug 14Option exercise5,781Aug 14, 2026